Inventiva announces FDA decision that Fast Track designation granted to lanifibranor in NASH encompasses the treatment of NASH with compensated cirrhosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to Inventiva announces FDA decision that Fast Track designation granted to lanifibranor in NASH encompasses the treatment of NASH with compensated cirrhosis
VALUERICH, Inc. (NASDAQ: IVA) Delayed: 3.41 -0.09 (2.57%)
Previous Close $3.50    52 Week High $0.40 
Open $3.44    52 Week Low $0.11 
Day High $3.58    P/E N/A 
Day Low $3.35    EPS $-0.03 
Volume 1,335,151       

VALUERICH, Inc. (NASDAQ: IVA) Delayed: 3.41 -0.09 (2.57%)
Previous Close $3.50    52 Week High $0.40 
Open $3.44    52 Week Low $0.11 
Day High $3.58    P/E N/A 
Day Low $3.35    EPS $-0.03 
Volume 1,335,151